CWM
AMPE

Cornerstone Wealth Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Cornerstone Wealth Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1K Hold
49
– – ﹤0.01% 442
2022
Q2 		$2K Hold
49
– – ﹤0.01% 445
2022
Q1 		$7K Hold
49
– – ﹤0.01% 461
2021
Q4 		$7K Hold
49
– – ﹤0.01% 499
2021
Q3 		$24K Hold
49
– – ﹤0.01% 451
2021
Q2 		$24K Buy
+49
New +$26.3K ﹤0.01% 471

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
SA
Shilanski & Associates Anchorage, Alaska $376M AUM 19.08% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return

Cornerstone Wealth Management's AMPE Position: Q3 2022 in Review

Cornerstone Wealth Management held its Ampio Pharmaceuticals Inc. (AMPE) position steady in Q3 2022 at 49 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #442.

Cornerstone Wealth Management first reported a position in AMPE in Q2 2021 and has held it in 6 quarters since. The position peaked at $24K in Q3 2021. 95 funds tracked by Wall St. Rank hold AMPE as of Q3 2022.

  • Cornerstone Wealth Management held 49 shares of Ampio Pharmaceuticals Inc. worth $1K as of Q3 2022.
  • Cornerstone Wealth Management left its Ampio Pharmaceuticals Inc. share count unchanged in Q3 2022.
  • Ampio Pharmaceuticals Inc. made up ﹤0.01% of Cornerstone Wealth Management's portfolio in Q3 2022, its #442 holding.
  • Cornerstone Wealth Management first reported a position in Ampio Pharmaceuticals Inc. in Q2 2021 and has held it in 6 quarters since.
  • Cornerstone Wealth Management's Ampio Pharmaceuticals Inc. position peaked at $24K in Q3 2021.
  • 95 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2022.

Based on Cornerstone Wealth Management's 13F filing for Q3 2022, filed 14 Oct 2022.